LONA

Conviction 0HealthcareScan · Mon, Aug 10, 2026

Bullish marubozu

LONA$7.75+0.91%

ResistanceSupportVol 14

Vol MA14 12.14K

May 11May 28Jun 16Jul 6Jul 23Aug 10

LeonaBio, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.leonabio.com ↗

Price7.75

Change+0.91%

Gap-4.56%

Rel volume0.21×

Avg volume17.74K

Avg $ vol134.87K

SMA 207.63

SMA 508.29

SMA 200—

Price vs 50-6.49%

Price vs 200—

MA stack—

50/200 cross—

Supertrenddown · 8.96

RSI (14)48

MACD hist0.09

MACD crossbull · 3d

Stoch %K / %D61 / 67

ADX (14)18

+DI / −DI21 / 21

RSI divergenceBullish

MACD divergence—

ATR %+7.65%

ADR %7.64%

52w high11.68

52w low4.34

From 52w high-33.65%

Above 52w low+78.57%

New 52w highNo

SqueezeOff

Bollinger width29.42%

%B0.55

Donchian pos31.31%

Donchian high10.01

Donchian low6.72

AVWAP (52w high)9.55

vs AVWAP high-18.88%

AVWAP (52w low)8.74

vs AVWAP low-11.33%

OBV trendDown

Chaikin MF (20)-0.21

Today vs 20d0.21×

Avg vol (14d)12.14K

Avg vol (20d)17.74K

Avg $ vol (20d)134.87K

Market cap72.8M

RS 3m (vs SPY)-27.81%

RS 6m (vs SPY)+46.22%

RS line new highNo

Trend template—

Technical rank52.4

1 week+3.75%

1 month-19.27%

3 months-22.81%

6 months+69.21%

1 year—

YTD+18.32%

P/E-0.69

P/B1.48

P/S—

P/FCF-1.59

EPS-24.70

Div yield—

ROE-214.20%

ROA-147.52%

Debt/Eq—

Current10.38

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-8.94%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value39.97M

Revenue—

Net income-32.95M

Gross profit—

Free cash flow-45.76M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out9.39M

Employees19

ListedFri, Sep 18, 2020

Free float6.17M

Float %66.1%

Short interest53.98K

Days to cover0.9d

Short volume60.4%

Squeeze score20 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$1.73

Last surprise—

Setup gradeD

Conviction0 / 100

Pattern quality—

Tech rank52.4 / 100

Group rank86 / 100 · Leading

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish marubozu

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in LONA

All disclosures →

No recent disclosed trades by Congress in LONA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in LONA · 10 buys

Insider	Side	Shares	Value	Traded	Filed
PERCEPTIVE ADVISORS LLC Director · Stock Option (Right to Buy) · 2026-04-09	Grant	28K	—	2026-04-09	2026-07-10
PERCEPTIVE ADVISORS LLC Director · Stock Option (Right to Buy) · 2026-06-23	Grant	28K	—	2026-06-23	2026-07-09
Callori Fred Director · Stock Option (Right to Buy) · 2026-06-23	Grant	2.33K	—	2026-06-23	2026-06-24
Callori Fred Director · Stock Option (Right to Buy) · 2026-05-05	Grant	56K	$0	2026-05-05	2026-05-07
Silverman Peter B. Director · Stock Option (Right to Buy) · 2026-05-05	Grant	56K	$0	2026-05-05	2026-05-07
Holles Natalie C. Director · Stock Option (Right to Buy) · 2026-05-05	Grant	56K	$0	2026-05-05	2026-05-07
San Martin Javier CHIEF MEDICAL OFFICER · Stock Option (Right to Buy) · 2026-04-09	Grant	350K	$0	2026-04-09	2026-04-13
Romano Kelly A Director · Stock Option (Right to Buy) · 2026-04-09	Grant	28K	$0	2026-04-09	2026-04-13
Litton Mark James PRESIDENT and CEO · Stock Option (Right to Buy) · 2026-04-09	Grant	750K	$0	2026-04-09	2026-04-13
Renninger Robert CHIEF FINANCIAL OFFICER · Stock Option (Right to Buy) · 2026-04-09	Grant	300K	$0	2026-04-09	2026-04-13

SEC filings

EDGAR filings in LONA · 1 recent

EDGAR →

8-K8-KShareholder voteTue, Jun 23, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.